Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist

N Zamberlan, R Castello, Roberto Castello, Davide Gatti, D Gatti, M Rossini, Maurizio Rossini, V Braga, E Fracassi, Elena Fracassi, S. Adámi, S Adami
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 1997 · vol. 7(2) , pp. 133–137 · doi:10.1007/bf01623688 · PMID:9166393 · W2913913277
article OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06+body, 2026-06-09 ⓘ

Gonadotropin-releasing hormone agonist therapy caused bone loss in hyperandrogenic women, which intermittent etidronate partially prevented.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Etidronic Acid Hirsutism Luteolytic Agents Osteoporosis Triptorelin Pamoate Adult Anthropometry Bone Density Bone Density Calcium Calcium Drug Therapy, Combination Etidronic Acid Female Hirsutism Hirsutism Humans Luteolytic Agents Luteolytic Agents Osteoporosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (25)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:10:57.821266+00:00
License: CC0 · commercial use OK